| human | Q5 |
| P735 | given name | Claire | Q1094751 |
| Claire | Q1094751 | ||
| P106 | occupation | researcher | Q1650915 |
| Q44896075 | A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection |
| Q21559730 | A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda |
| Q36172128 | Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding |
| Q34583552 | Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir |
| Q35797743 | CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q27487966 | Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness |
| Q36010191 | Comprehensive analysis of unique cases with extraordinary control over HIV replication |
| Q34611170 | Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques |
| Q45404246 | Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus |
| Q37410726 | Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. |
| Q73496374 | Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function |
| Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
| Q35140055 | Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons |
| Q37212990 | Effect of antiretroviral therapy on HIV reservoirs in elite controllers |
| Q36379282 | Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy |
| Q39606566 | Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings |
| Q36783609 | Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy |
| Q37033269 | Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies |
| Q34762506 | Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals |
| Q34755325 | Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy |
| Q34097573 | HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir |
| Q78342521 | HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors |
| Q36540073 | Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. |
| Q33977594 | IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation |
| Q33285471 | Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells |
| Q56879617 | Innate Immunity in HIV Infection |
| Q56879621 | Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions |
| Q45728575 | Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function |
| Q59313649 | Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients |
| Q44517872 | Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters |
| Q74676097 | Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells |
| Q37054526 | Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control |
| Q34588169 | Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy |
| Q35022773 | Perturbations in B cell responsiveness to CD4 + T cell help in HIV-infected individuals |
| Q43833986 | Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection |
| Q35158133 | Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication |
| Q35016645 | Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy |
| Q36602397 | Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals |
| Q45732447 | Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy |
| Q34200151 | The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences |
| Q33839468 | Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles |
Search more.